High-throughput characterization of virus-like particles by interlaced size-exclusion chromatography
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal AdministrationClinical and Vaccine Immunology, 2012
- A sub-two minutes method for monoclonal antibody-aggregate quantification using parallel interlaced size exclusion high performance liquid chromatographyJournal of Chromatography A, 2011
- Safety and immunogenicity of a candidate parvovirus B19 vaccineVaccine, 2011
- Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung MetastasesCancer Research, 2011
- Size and Shape of Protein Molecules at the Nanometer Level Determined by Sedimentation, Gel Filtration, and Electron MicroscopyBiological Procedures Online, 2009
- Rational Design of a Stable, Freeze-Dried Virus-Like Particle-Based Vaccine FormulationDrug Development and Industrial Pharmacy, 2009
- Protection against lethal challenge by Ebola virus-like particles produced in insect cellsVirology, 2009
- Quantitative characterization of virus‐like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopyBiotechnology and Bioengineering, 2008
- Characterization of the large size aggregation of Hepatitis B virus surface antigen (HBsAg) formed in ultrafiltration processProcess Biochemistry, 2007
- Stabilization of human papillomavirus virus-like particles by non-ionic surfactantsJournal of Pharmaceutical Sciences, 2005